Biotech catalyst calendar

Clinical trial readouts are some of the biggest moves in biotech stocks. These are the Phase 3 trials run by publicly traded companies whose primary completion date, when the main result is measured, falls in the next 60 days. Companies usually announce topline results within weeks to a few months of it, and most dates are the company's own estimate. From the official ClinicalTrials.gov registry, linked to stock tickers. Updated Nov 02, 2026 07:08 UTC.